These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


363 related items for PubMed ID: 36164451

  • 1. Primary and Triage Cervical Screening Diagnostic Value of Methods for the Detection of Cervical Dysplasia.
    Njue JK, Muturi M, Kamau L, Lwembe R.
    Biomed Res Int; 2022; 2022():1930102. PubMed ID: 36164451
    [Abstract] [Full Text] [Related]

  • 2. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.
    Ciotti M, Sesti F, Paba P, Benedetto A, Patrizi L, Criscuolo A, Piccione E, Branca M, Syrjänen K, Favalli C.
    Eur J Gynaecol Oncol; 2004; 25(5):577-84. PubMed ID: 15493169
    [Abstract] [Full Text] [Related]

  • 3. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
    Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, McIntosh KM, Pawlick GF, Hiatt RA.
    JAMA; 1999 May 05; 281(17):1605-10. PubMed ID: 10235153
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
    Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, Koutsky LA.
    JAMA; 2002 Oct 09; 288(14):1749-57. PubMed ID: 12365959
    [Abstract] [Full Text] [Related]

  • 5. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?
    Ferris DG, Wright TC, Litaker MS, Richart RM, Lorincz AT, Sun XW, Borgatta L, Buck H, Kramer L, Rubin R.
    J Fam Pract; 1998 Feb 09; 46(2):125-34. PubMed ID: 9487318
    [Abstract] [Full Text] [Related]

  • 6. Improved abnormal Pap smear triage using cervical cancer biomarkers.
    Killeen JL, Dye T, Grace C, Hiraoka M.
    J Low Genit Tract Dis; 2014 Jan 09; 18(1):1-7. PubMed ID: 23760145
    [Abstract] [Full Text] [Related]

  • 7. Performance of the Roche AMPLICOR human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear.
    Monsonego J, Bohbot JM, Pollini G, Krawec C, Vincent C, Merignargues I, Haroun F, Sednaoui P, Monfort L, Dachez R, Syrjänen K.
    Gynecol Oncol; 2005 Oct 09; 99(1):160-8. PubMed ID: 16023184
    [Abstract] [Full Text] [Related]

  • 8. Comparing Papanicolau smear, visual inspection with acetic acid and human papillomavirus cervical cancer screening methods among HIV-positive women by immune status and antiretroviral therapy.
    Chung MH, McKenzie KP, De Vuyst H, Richardson BA, Rana F, Pamnani R, Njoroge JW, Nyongesa-Malava E, Sakr SR, John-Stewart GC, Mugo NR.
    AIDS; 2013 Nov 28; 27(18):2909-19. PubMed ID: 23842133
    [Abstract] [Full Text] [Related]

  • 9. HPV testing in first-void urine provides sensitivity for CIN2+ detection comparable with a smear taken by a clinician or a brush-based self-sample: cross-sectional data from a triage population.
    Leeman A, Del Pino M, Molijn A, Rodriguez A, Torné A, de Koning M, Ordi J, van Kemenade F, Jenkins D, Quint W.
    BJOG; 2017 Aug 28; 124(9):1356-1363. PubMed ID: 28391609
    [Abstract] [Full Text] [Related]

  • 10. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.
    Zorzi M, Del Mistro A, Farruggio A, de'Bartolomeis L, Frayle-Salamanca H, Baboci L, Bertazzo A, Cocco P, Fedato C, Gennaro M, Marchi N, Penon MG, Cogo C, Ferro A.
    BJOG; 2013 Sep 28; 120(10):1260-7; discussion 1267-8. PubMed ID: 23786222
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
    Veijalainen O, Kares S, Kujala P, Tirkkonen M, Vuento R, Kholová I, Luukkaala T, Osuala V, Mäenpää J.
    Acta Obstet Gynecol Scand; 2016 Nov 28; 95(11):1220-1227. PubMed ID: 27591407
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China.
    Pan QJ, Hu SY, Guo HQ, Zhang WH, Zhang X, Chen W, Cao J, Jiang Y, Zhao FH, Qiao YL.
    Gynecol Oncol; 2014 May 28; 133(2):172-9. PubMed ID: 24631450
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical correlation of cervical cancer screening using Pap smear test.
    Sharif YH.
    J Popul Ther Clin Pharmacol; 2022 May 28; 29(1):e1-e8. PubMed ID: 35686892
    [Abstract] [Full Text] [Related]

  • 17. Performance of standardised colposcopy to detect cervical precancer and cancer for triage of women testing positive for human papillomavirus: results from the ESTAMPA multicentric screening study.
    Valls J, Baena A, Venegas G, Celis M, González M, Sosa C, Santin JL, Ortega M, Soilán A, Turcios E, Figueroa J, Rodríguez de la Peña M, Figueredo A, Beracochea AV, Pérez N, Martínez-Better J, Lora O, Jiménez JY, Giménez D, Fleider L, Salgado Y, Martínez S, Bellido-Fuentes Y, Flores B, Tatti S, Villagra V, Cruz-Valdez A, Terán C, Sánchez GI, Rodríguez G, Picconi MA, Ferrera A, Mendoza L, Calderón A, Murillo R, Wiesner C, Broutet N, Luciani S, Pérez C, Darragh TM, Jerónimo J, Herrero R, Almonte M, ESTAMPA study group.
    Lancet Glob Health; 2023 Mar 28; 11(3):e350-e360. PubMed ID: 36796982
    [Abstract] [Full Text] [Related]

  • 18. HPV testing for triage of HIV-infected women with papanicolaou smears read as atypical squamous cells of uncertain significance.
    Massad LS, Schneider MF, Watts DH, Strickler HD, Melnick S, Palefsky J, Anastos K, Levine AM, Minkoff H.
    J Womens Health (Larchmt); 2004 Mar 28; 13(2):147-53. PubMed ID: 15072728
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of several screening approaches for detection of cervical lesions in rural Shandong, China.
    Zong LJ, Zhang YZ, Yang XS, Jiang J, Cui BX, Qiao YB, Li L, Jiang K, Zhang WJ, Kong BH, Shen K.
    Asian Pac J Cancer Prev; 2015 Mar 28; 16(5):1907-12. PubMed ID: 25773843
    [Abstract] [Full Text] [Related]

  • 20. Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico.
    Salmerón J, Lazcano-Ponce E, Lorincz A, Hernández M, Hernández P, Leyva A, Uribe M, Manzanares H, Antunez A, Carmona E, Ronnett BM, Sherman ME, Bishai D, Ferris D, Flores Y, Yunes E, Shah KV.
    Cancer Causes Control; 2003 Aug 28; 14(6):505-12. PubMed ID: 12948281
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.